{"id":"W3135702916","doi":"10.1111/all.14809","title":"Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines","year":2021,"lang":"en","type":"review","venue":"Allergy","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Horizon 2020 Framework Programme; Allergopharma; Idorsia Pharmaceuticals; Hospital for Sick Children; Sanofi; European Commission; Allergy Therapeutics; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Innovationsfonden; Teva Pharmaceutical Industries; Regeneron Pharmaceuticals; AstraZeneca; National Science Foundation","keywords":"Medicine; Nasal polyps; Mepolizumab; Omalizumab; Internal medicine; Cochrane Library; Relative risk; Adverse effect; Dupilumab; Sinusitis; Confidence interval; Chronic rhinosinusitis; Surgery; Asthma; Immunoglobulin E; Immunology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01124167,0.001702744,0.01124997,0.008486523,0.0007214751,0.003045104,0.001921586,0.003019571,0.006382836],"category_scores_gemma":[0.04322663,0.001115514,0.01198629,0.00613744,0.0009438373,0.002617771,0.001741251,0.00172515,0.0005288878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004592943,"about_ca_system_score_gemma":0.01110013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009833105,"about_ca_topic_score_gemma":0.02363606,"domain_scores_codex":[0.9904441,0.003280998,0.003693936,0.0006824161,0.001671486,0.000227],"domain_scores_gemma":[0.9783698,0.01402968,0.004788042,0.0003241867,0.002247177,0.0002411456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002858801,0.00001398534,0.0003144834,0.9538388,0.01043122,0.00003947484,0.00007695641,0.0000635293,0.000120847,0.0002262145,0.001970268,0.03261825],"study_design_scores_gemma":[0.0004896303,0.0001715059,0.001604223,0.9169204,0.06365871,0.0001514249,0.00008332896,0.00006354556,0.0001129908,0.0002915756,0.01642126,0.00003140595],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004370499,0.9976986,0.0001434969,0.0004385527,0.0001634038,0.0004567994,0.0003946711,0.000009431324,0.000257932],"genre_scores_gemma":[0.008692853,0.986991,0.00118383,0.001154299,0.0001353869,0.001287509,0.0003264634,0.000008819649,0.0002198251],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01124997,"threshold_uncertainty_score":0.05945235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0920092648072491,"score_gpt":0.3819486176143602,"score_spread":0.2899393528071111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}